NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Research on breast cancer detailed by scientists at Vanderbilt University



May 15th, 2008

"The mitochondrial DNA (mtDNA) 4977-bp deletion (Delta mtDNA(4977) mutation) is one of the most frequently observed mtDNA mutations in human tissues and may play a role in carcinogenesis. Only a few studies have evaluated Delta mtDNA(4977) mutation in breast cancer tissue, and the findings have been inconsistent, which may be due to methodological differences," investigators in the United States report.

"In this study, we developed a quantitative real-time PCR assay to assess the level of the Delta mtDNA(4977) mutation in tumor tissue samples from 55 primary breast cancer patients and 21 patients with benign breast disease (BBD). The Delta mtDNA(4977) mutation was...


Source: Women's Health Weekly (2008-05-15)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login